Thrombospondin 2 promotes tumor metastasis by inducing matrix metalloproteinase-13 production in lung cancer cells
Authors:
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 155, 537-546
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology (MOST106-2314-B-341-001-MY3, MOST106-2320-B-030-005-)
- Medical Research Foundation (CMRPF6E0081, CMRPF6E0082, CMRPF6E0083)
- Shin-Kong Wu Ho-Su Memorial Hospital (105-SKH-FJU-08)
This publication has 41 references indexed in Scilit:
- Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2Cold Spring Harbor Perspectives in Medicine, 2012
- IL-6 Increases MMP-13 Expression and Motility in Human Chondrosarcoma CellsJournal of Biological Chemistry, 2011
- CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivoBreast Cancer Research and Treatment, 2010
- Matrix metalloproteinase 13–deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte developmentArthritis & Rheumatism, 2009
- MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinomaCarcinogenesis, 2009
- Genetic and cell biological analysis of integrin outside-in signalingGenes & Development, 2009
- Integrin signalling at a glanceJournal of Cell Science, 2009
- Thrombospondins: from structure to therapeuticsCellular and Molecular Life Sciences, 2008
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- The Secreted Protein Thrombospondin 2 Is an Autocrine Inhibitor of Marrow Stromal Cell ProliferationJournal of Bone and Mineral Research, 2002